gms | German Medical Science

64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

26. - 29. Mai 2013, Düsseldorf

Intraoperative resection control with contrast enhanced 3D-ultrasound – first results in patients with glioblastoma

Meeting Abstract

  • Felix Arlt - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig
  • Claire Chalopin - ICCAS (Innovation Centre Computer Assisted Surgery), Leipzig
  • Andrea Müns - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig
  • Jürgen Meixensberger - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig; ICCAS (Innovation Centre Computer Assisted Surgery), Leipzig
  • Dirk Lindner - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig

Deutsche Gesellschaft für Neurochirurgie. 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Düsseldorf, 26.-29.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. DocMI.06.09

doi: 10.3205/13dgnc330, urn:nbn:de:0183-13dgnc3306

Veröffentlicht: 21. Mai 2013

© 2013 Arlt et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: A convincing intraoperative resection control in surgery of malignant brain tumors is associated with a longer overall survival of the patients. B-mode ultrasound (BUS) is a well known intraoperative imaging application in neurosurgical procedure but it's limited in the differentiation of tumor, tumor borders, edema or tumor remnants.

The aim of this clinical study is the investigation of contrast enhanced and 3D-reconstructed ultrasound (CEUS) in surgery of glioblastoma regarding the uptake of the contrast agent after tumor resection, imaging quality and comparison with the postoperative MRi.

Method: We investigated prospectively 20 patients suffering from a glioblastoma multiforme (GBM). All have undergone surgery with the support of neuronavigation in our Department of Neurosurgery. The median age was 61 years (range from 27 to 79 years).

Ultrasound imaging for resection control was acquired at the end of tumor resection defined by the neurosurgeon. A high end ultrasound (US) device (Toshiba Aplio XG®) with linear probes for B-Mode and contrast mode was used. The navigation and 3D reconstruction was performed with the LOCALITE SonoNavigator® and the images were transferred digitally. The used contrast agent was SonoVue® by Bracco®. Subsequently the ultrasound images were segmented with itk-Snap® and compared to the corresponding postoperative MR data.

Results: In 17 of the 20 tumors we noticed a high contrast uptake while in 3 patients the uptake was slightly and not sufficient. In five of these 17 patients the postoperative MRi as well as the intraoperative CEUS for resection control showed tumor remnants. No further resection was performed because of eloquent location of these tumors. In the remaining 12 patients a gross total resection was planned preoperatively. In all patients the postoperative MRi demonstrated complete resection. 6/12 showed a small contrast enhancement lower than 0.175 cm3. In four of these six patients the resection control with CEUS could visualized also small contrast enhancement (mean size 0,85 ml).

Conclusions: 3D-contrast enhanced intraoperative ultrasound (CEUS) is a save and convincing intraoperative imaging modality. High resolution images in real time 3D could be acquired in 5 to 10 minutes. Gross total resection and incomplete resection of glioblastoma were sufficient demonstrated with CEUS intraoperatively. The application of US contrast agent could be a helpful imaging tool for resection control.in glioblastoma.